Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
As of September 2023 it is on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks, and the agency has scheduled a Pharmacy Compounding Advisory Committee (PCAC) review for July 2026 covering proposed uses in opioid withdrawal, chronic insomnia, and narcolepsy
The anti-aging properties of GHK-Cu reflect its fundamental role in maintaining tissue homeostasis and counteracting age-related decline in regenerative capacity
After approval, your preauthorized card will be charged, and a shipping label will be created
Face and neck Facial skin serves as the primary application area for most copper peptide users
Were global leaders in NAD+ research With 70,000+ NAD+ users supported and multiple peer-reviewed clinical trials, our in-house Stanford PhD-led Research Team is setting the benchmark for research-driven, clinician-guided NAD+ protocols
The NAD+ research guide covers the biology, and NAD+ is available for research
US$ 29.83
US$ 22.82
US$ 22.74
US$ 21.51
US$ 28.23
US$ 29.33
